They still haven't addressed the 88% failure rate of tPA. Or the fact that the neuronal cascade of death continues even after tPA administration.
Big Whoopee.
Failure, failure, failure. More proof that no ones thinks in the stroke medical world.
http://medicalresearch.com/stroke/stroke_more_patients_getting_faster_treatment_fewer_complications/4932/
MedicalResearch.com: What are the main findings of the study?
Dr. Fonarow: This study examined data from
hospitals that have adopted the American Heart Association/ American
Stroke Association’s national quality initiative, Target: Stroke, which
aims to increase the number of stroke patients treated with
clot-busting drugs for ischemic stroke within 60 minutes or less after
hospital arrival. Initiated nationwide in 2010, Target: Stroke provided
10 key strategies as well as tools to facilitate timely tPA
administration, as well as additional approaches to improve stroke care
and outcome.
Data from 71,169 tPA-treated stroke patients at 1,030 hospitals
participating in Target: Stroke were analyzed to compared the time to
treatment and incidence of complications before implementation, from
2003 to 2009, to the post-implementation years, from 2010 to 2013.
This study found that the percentage of patients treated within the
recommended timeframe increased from less than one-third before Target:
Stroke to more than half afterwards. The Target: Stroke program goal of
50 percent or more of patients having door-to-needle times within 60
minutes was successfully achieved. In addition, the average time to
treatment dropped by 15 minutes, from 74 to 59 minutes.
Faster treatment was associated with lower rates of complications,
including death. Before Target: Stroke, 9.9% of stroke patients died in
the hospital, compared to 8.3% of patients treated after the initiative
started, a difference which was statistically significant. In addition,
patients treated by Target: Stroke strategies were less likely to
develop the complication of symptomatic intracranial hemorrhage.
More blather at the link.
No comments:
Post a Comment